Company News
Piramal Pharma Exercises Call Option for Yapan Bio
Piramal Pharma's board committee approved exercising a call option to acquire an additional 41% stake in associate company Yapan Bio.
The acquisition will increase Piramal's holding in Yapan Bio from
